A Phase 4 interventional study of ESP Block with Bupivacaine and ESP Block with Bupivacaine + Liposomal Bupivacaine in Postoperative Pain, sponsored by Duke University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Duke University · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Pain, Postoperative by Duke University — 6 open to participants now, 6 under way, none of them phase 3. Pain, Postoperative · Duke University.
Among the 19 studies in Pain, Postoperative by Duke University, this one is the 7th largest by planned enrollment of the 17 interventional ones that give a count, is one of 4 that started in 2026, is one of 11 in phase 4, and was the 16th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →6 of the 19 studies in Pain, Postoperative by Duke University are open now, in 1 country. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 18+ · Healthy volunteers
Duke University · Sites in United States
Ages 3–17 · Healthy volunteers
Duke University
Ages 18+ · Healthy volunteers
Duke University
Ages 18–80
Duke University
Ages 18–90 · Women only
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 75 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 53 across the 17 interventional studies, 36 across the 2 observational. Of the 11 that completed or were terminated, 8 (73%) have results posted.
This tab as a report to print or save as PDF → With an account.
Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
2 of the studies in Pain, Postoperative by Duke University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07068243Duke UniversityREctus Sheath Trial | 2027-02 |
| NCT07566312Duke UniversityStudy of QL Analgesic Response and Extent | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 19 studies in Pain, Postoperative by Duke University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective randomized double-blind study evaluates the efficacy of erector spinae plane (ESP) blocks on postoperative pain in patients undergoing cervical or lumbar posterior spinal fusion. Patients will receive either 0.5% bupivacaine plus liposomal bupivacaine or 0.5% plain bupivacaine. Outcomes include opioid consumption over 72 hours, pain scores, length of stay, and time to ambulation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Group 1 receives ESP block with 0.5% bupivacaine plus liposomal bupivacaine.
Drug: ESP Block with Bupivacaine + Liposomal Bupivacaine
Group 2 receives ESP block with 0.5% plain bupivacaine.
Drug: ESP Block with Bupivacaine
Cervical and lumbar ESP blocks performed under ultrasound guidance using plain bupivacaine.
Cervical and lumbar ESP blocks performed under ultrasound guidance using bupivacaine admixed with liposomal bupivacaine.
Postoperative Pain as measured by opiate consumption
Morphine MilliEquivalents
Time frame: 72 hours
Postoperative Pain at rest and with movement as measured by patient reported pain scores
Numeric Rating Scale (0-10) 0 being no pain, 10 being worst pain imaginable
Time frame: 4, 8, 12, 24, 48, and 72 hours
Discharge Readiness
Hospital and PACU Length of Stay
Time frame: 72 hours
Postoperative Pain Severity as measured by required time for patient controlled-analgesia
Duration of patient controlled analgesia use
Time frame: 72 hours
Incidents of post-operative nausea and vomiting
Post-operative Nausea and Vomiting
Time frame: 72 hours
Time to first ambulation
Time frame: 72 hours
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Jan 2028, 16 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 16 months is close to that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
Start moved once since we started tracking on Sep 25, 2026: Oct 2027 → Sep 2026, on Oct 26, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.